Stocktoria
Hinge Health, Inc. HNGE
Hinge Health, Inc. (HNGE) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $587.9M at a -89.9% net margin.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-24 | Wells Fargo | Overweight (main) |
| 2026-06-17 | Baird | Neutral (main) |
| 2026-06-15 | Raymond James | Outperform (main) |
| 2026-06-15 | Canaccord Genuity | Buy (main) |
| 2026-06-12 | Keybanc | Overweight (main) |
| 2026-06-11 | RBC Capital | Outperform (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.23 |
| Retained earnings / assets | -1.411 |
| EBIT / assets | -0.734 |
| Equity / liabilities | 0.488 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| HNGE | Hinge Health, Inc. | 4/9 | -7.51 | — | +50.6% |
| SOHU | Sohu.com Ltd | 5/9 | 6.98 | 0.8 | -2.4% |
| APLD | Applied Digital Corp. | — | -1.76 | — | +167.5% |
| IBEX | IBEX Ltd | 6/9 | 4.05 | 10.9 | +9.8% |
| TRVG | trivago N.V. | 3/9 | -3.1 | — | +19.1% |
| LIF | Life360, Inc. | 5/9 | 4.54 | 28.5 | +31.8% |
| CARS | Cars.com Inc. | 6/9 | -1.06 | 30 | +0.6% |
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
FAQ
Is HNGE financially healthy?
Hinge Health, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does HNGE pay a dividend?
No, Hinge Health, Inc. does not currently pay a dividend.
How profitable is HNGE?
In FY2025, Hinge Health, Inc. had a net margin of -89.9% and a return on equity of -295.7%.
What is the analyst price target for HNGE?
The average Wall-Street price target for Hinge Health, Inc. is $82.07, about 4.9% below the recent price, from 15 analysts (consensus: buy).
Is HNGE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Hinge Health, Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.